| Dr Robert J Boeglin Jr, MD | |
|
4633 Crystal Lake Ln, Indianapolis, IN 46240-6417 | |
| (317) 654-5128 | |
| (317) 848-9990 |
| Full Name | Dr Robert J Boeglin Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 4633 Crystal Lake Ln, Indianapolis, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740483080 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01033733A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Boeglin Jr, MD 4633 Crystal Lake Ln, Indianapolis, IN 46240-6417 Ph: (317) 654-5128 | Dr Robert J Boeglin Jr, MD 4633 Crystal Lake Ln, Indianapolis, IN 46240-6417 Ph: (317) 654-5128 |
News Archive
The Paul Scherrer Institute (PSI) has developed a new breast cancer diagnostic method, and is now carrying out first tests on non-preserved human tissue in conjunction with the Kantonsspital Baden AG. This new method should be able to reveal structures that cannot be seen using conventional mammography. Standard procedures only determine the extent to which X-rays are attenuated by various tissue structures.
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.
New research published in the January 2016 issue of The FASEB Journal suggests that the G-protein-coupled receptor 119 (GPR119) could be a viable treatment target for nonalcoholic fatty liver disease. This receptor has already been identified as a drug target for diabetes and obesity, and this report raises hopes that compounds that target GPR119 for diabetes or obesity might also work for non-alcoholic fatty liver disease.
"The reforms I'm proposing would not apply to those who are here illegally," President Obama said in a carefully worded statement to a Joint Session of Congress and the American public last night. The problem, notes the Federation for American Immigration Reform (FAIR), is that the health care reforms proposed in H.R. 3200, America's Affordable Health Care Act of 2009, clearly would benefit illegal aliens.
› Verified 6 days ago
Dr. Frank N. Hrisomalos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1070, Indianapolis, IN 46290 Phone: 317-817-1500 Fax: 317-817-1511 | |
Dr. Sang Hoon Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9002 N Meridian St, Suite 102, Indianapolis, IN 46260 Phone: 317-573-4410 Fax: 317-573-4412 | |
Dr. David V Poer, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8902 N Meridian St, Ste 120, Indianapolis, IN 46260 Phone: 317-582-1118 Fax: 317-582-1116 | |
Scott Hobson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St, Suite 2020, Indianapolis, IN 46290 Phone: 317-817-1976 Fax: 317-817-1737 | |
John Thomas Minturn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Suite #1030, Indianapolis, IN 46290 Phone: 317-817-1586 Fax: 317-817-1399 | |
Amir Reza Hajrasouliha, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 W Michigan St, Indianapolis, IN 46202 Phone: 317-944-2020 | |
Keith R Knuth, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 901 E 86th St, Indianapolis, IN 46240 Phone: 317-844-5500 Fax: 317-573-4230 |